Advisory Committees; Filing of Annual Reports, 74325 [05-24039]

Download as PDF Federal Register / Vol. 70, No. 240 / Thursday, December 15, 2005 / Notices a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0249. The approval expires on October 31, 2008. A copy of the supporting statement for this information collection is available on the Internet at https://www.fda.gov/ ohrms/dockets. Dated: December 8, 2005. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. 05–24042 Filed 12–14–05; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Advisory Committees; Filing of Annual Reports AGENCY: Food and Drug Administration, Medical Devices Advisory Committee (consisting of reports for the Dental Products Panel; Ear, Nose, and Throat Devices Panel; Neurology Devices Panel; and Orthopaedic and Rehabilitation Devices Panel) Annual reports are available for public inspections between 9 a.m. and 4 p.m., Monday through Friday, at the following locations: 1. The Library of Congress, Madison Bldg., Newspaper and Current Periodical Reading Room, 101 Independence Ave. SE., rm. 133, Washington, DC; and 2. The Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Dated: December 2, 2005. Jason Brodsky, Acting Associate Commissioner for External Relations. [FR Doc. 05–24039 Filed 12–14–05; 8:45 am] BILLING CODE 4160–01–S HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that, as required by the Federal Advisory Committee Act, the agency has filed with the Library of Congress the annual reports of those FDA advisory committees that held closed meetings during fiscal year 2005. ADDRESSES: Copies are available from the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852, 301–827– 6860. FOR FURTHER INFORMATION CONTACT: Theresa L. Green, Advisory Committee Oversight and Management Staff (HF– 4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–827–1220. SUPPLEMENTARY INFORMATION: Under section 13 of the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR 14.60(c), FDA has filed with the Library of Congress the annual reports for the following FDA advisory committees that held closed meetings during the period October 1, 2004, through September 30, 2005. Center for Biologics Evaluation and Research: Blood Products Advisory Committee Cellular, Tissue and Gene Therapies Advisory Committee (formerly the Biological Response Modifiers Advisory Committee) Vaccines and Related Biological Products Advisory Committee Center for Devices and Radiological Health: SUMMARY: VerDate Aug<31>2005 17:24 Dec 14, 2005 Jkt 208001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Indian Health Service [Funding Opportunity Number: HHS–2006– IHS–TSGP–0002; CFDA Number: 93.210] Tribal Self-Governance Program; Negotiation Cooperative Agreement; New Funding Cycle for Fiscal Year 2006 Key Dates: Applications Due—January 20, 2006; Objective Review Committee to Evaluate Applications—March 8–9, 2006; Anticipated Project Start Date— April 1, 2006. I. Funding Opportunity Description The purpose of the program is to award cooperative agreements that provide negotiation resources to Tribes interested in participating in the Tribal Self-Governance Program (TSGP) as authorized by Title V, Tribal SelfGovernance Amendments of 2000 of the Indian Self-Determination and Education Assistance Act of Public Law (Pub. L.) 93–638, as amended. The TSGP is designed to promote selfdetermination by allowing Tribes to assume more control of Indian Health Service (IHS) programs and services through compacts negotiated with the IHS. The Negotiation Cooperative Agreement provides Tribes with funds to help cover the expenses involved in preparing for and negotiating with the IHS and assists eligible Indian Tribes to prepare for Compacts and Funding Agreements (FAs) with an effective date of October 1, 2006, or January 1, 2007. PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 74325 The Negotiation Cooperative Agreement provides resources to assist Indian Tribes to conduct negotiation activities that include but are not limited to: • Analysis of the complex IHS budget to determine what programs, services, functions, and activities (PSFAs) will be negotiated. • Development of the terms and conditions that will be set forth in a Compact and Funding Agreement (FA). • Consultant costs such as Attorney or Financial Advisors. • Communication Costs. • Identification of Tribal shares that will be included in the FA. The award of a Negotiation Cooperative Agreement is not required as a prerequisite to enter the TSGP. Indian Tribes that have completed comparable health planning activities in previous years using tribal resources but have not received a Tribal selfgovernance planning award are also eligible to apply. Applicants must provide a statement that the planning phase has been conducted to the satisfaction of the Indian Tribe and must include: (a) Legal and budgetary research; and (b) internal Tribal government planning and organizational preparation relating to the administration of health programs. II. Award Information Type of Award: Cooperative Agreement. Estimated Funds Available: The total amount identified for Fiscal Year (FY) 2006 is $240,000 for approximately twelve (12) Tribes to enter the TSGP negotiation process for compacts beginning in Fiscal Year (FY) 2007 or Calendar Year (CY) 2007. Awards under this announcement are subject to the availability of funds. Anticipated Number of Awards: The estimated number of awards to be funded is approximately 12. Project Period: 12 months. Award Amount: $20,000 per year. Programmatic Involvement: IHS TSGP funds will be awarded as cooperative agreements and will have substantial programmatic involvement to establish a process through which Tribes can effectively approach the IHS to identify programs and associated funding which could be incorporated into programs. The IHS roles and responsibilities will include: • Identification of IHS staff that will consult with applicants on methods used by the IHS to manage and deliver health care. • Provide applicants with a list of laws and regulations that provide authority for the various IHS programs. E:\FR\FM\15DEN1.SGM 15DEN1

Agencies

[Federal Register Volume 70, Number 240 (Thursday, December 15, 2005)]
[Notices]
[Page 74325]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-24039]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Advisory Committees; Filing of Annual Reports

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that, as 
required by the Federal Advisory Committee Act, the agency has filed 
with the Library of Congress the annual reports of those FDA advisory 
committees that held closed meetings during fiscal year 2005.

ADDRESSES:  Copies are available from the Division of Dockets 
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, 
rm. 1061, Rockville, MD 20852, 301-827-6860.

FOR FURTHER INFORMATION CONTACT:  Theresa L. Green, Advisory Committee 
Oversight and Management Staff (HF-4), Food and Drug Administration, 
5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.

SUPPLEMENTARY INFORMATION: Under section 13 of the Federal Advisory 
Committee Act (5 U.S.C. app. 2) and 21 CFR 14.60(c), FDA has filed with 
the Library of Congress the annual reports for the following FDA 
advisory committees that held closed meetings during the period October 
1, 2004, through September 30, 2005.
Center for Biologics Evaluation and Research:
    Blood Products Advisory Committee
    Cellular, Tissue and Gene Therapies Advisory Committee (formerly 
the Biological Response Modifiers Advisory Committee)
    Vaccines and Related Biological Products Advisory Committee
Center for Devices and Radiological Health:
    Medical Devices Advisory Committee (consisting of reports for the 
Dental Products Panel; Ear, Nose, and Throat Devices Panel; Neurology 
Devices Panel; and Orthopaedic and Rehabilitation Devices Panel)
    Annual reports are available for public inspections between 9 a.m. 
and 4 p.m., Monday through Friday, at the following locations:
    1. The Library of Congress, Madison Bldg., Newspaper and Current 
Periodical Reading Room, 101 Independence Ave. SE., rm. 133, 
Washington, DC; and
    2. The Division of Dockets Management (HFA-305), Food and Drug 
Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852.

    Dated: December 2, 2005.
Jason Brodsky,
Acting Associate Commissioner for External Relations.
[FR Doc. 05-24039 Filed 12-14-05; 8:45 am]
BILLING CODE 4160-01-S

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.